Banner - NPPA Connect
Opinion|Videos|September 12, 2024

Comprehensive Analysis: Upa Outshines Dupi Across Key Measures

Dermatology experts analyze the superior outcomes of upadacitinib compared with dupilumab across key efficacy measures in atopic dermatitis treatment.